Body

“The purpose of the panel is to provide transparent, unbiased analysis of the industrywide progress made in improving direct-to-consumer advertising consistent with the new guidelines,” says Billy Tauzin, PhRMA president and CEO. “America’s pharmaceutical research companies are committed to providing valuable information to consumers, which will then allow patients and providers to make better health care decisions.”
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Add new comment